Metastatic Melanoma

Showing NaN - NaN of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

Not yet recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 9, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 12, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +12 more
  • Tucson, Arizona
  • +60 more
Jan 11, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Phoenix, Arizona
  • +48 more
Jan 3, 2023

Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

Recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel
  • +5 more
  • La Jolla, California
  • +44 more
Dec 16, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

Recruiting
  • Unresectable Melanoma
  • +3 more
  • Sargramostim (GM-CSF)
  • Pembrolizumab (anti-PD-1)
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)

Completed
  • Metastatic Melanoma
  • Placebo for antibiotic
  • +4 more
  • Los Angeles, California
  • +6 more
Jun 7, 2022

Metastatic Melanoma Trial in Boston (Pembrolizumab, Infliximab, Placebo)

Recruiting
  • Metastatic Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Apr 6, 2022

Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

Recruiting
  • Metastatic Melanoma
  • Miami, Florida
  • +4 more
Mar 29, 2022

Metastatic Melanoma Trial in Boston (Tremelimumab, MEDI3617)

Active, not recruiting
  • Metastatic Melanoma
  • Boston, Massachusetts
  • +1 more
Mar 22, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in France, United States (Nivolumab, Ipilimumab, Placebo)

Completed
  • Unresectable Melanoma
  • Metastatic Melanoma
  • San Francisco, California
  • +20 more
Feb 16, 2022

Metastatic Melanoma Trial in United States (ipilimumab, nivolumab)

Active, not recruiting
  • Metastatic Melanoma
  • Hartford, Connecticut
  • +11 more
Mar 10, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

Terminated
  • BRAF V600E Mutation Present
  • +7 more
  • Boston, Massachusetts
  • +1 more
Mar 9, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021

Melanoma, Metastatic Melanoma Trial in Boston (Ipilimumab, Nivolumab, Troriluzole)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
  • +1 more
Sep 17, 2021

Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)

Active, not recruiting
  • Advanced Cancer
  • +3 more
  • Washington, District of Columbia
  • +12 more
Sep 2, 2021

Metastatic Melanoma Trial in Switzerland, United States (RAF265)

Completed
  • Metastatic Melanoma
  • Aurora, Colorado
  • +10 more
Dec 11, 2020

Metastatic Melanoma Trial in United States (NEO-PV-01, Nivolumab, Adjuvant)

Terminated
  • Metastatic Melanoma
  • NEO-PV-01
  • +4 more
  • Scottsdale, Arizona
  • +7 more
Sep 1, 2020

Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

Completed
  • Cancer
  • +18 more
  • ASN007: ascending doses
  • ASN007 RD
  • Tampa, Florida
  • +4 more
Jul 7, 2020

Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)

Completed
  • Advanced Melanoma
  • Metastatic Melanoma
  • Los Angeles, California
  • +13 more
Nov 14, 2019